The finger-clip device used in nearly every sleep study to score how severe a patient's obstructive sleep apnea is may be systematically underestimating the condition in Black patients, according to a new analysis published in the American Journal of Respiratory and Critical Care Medicine.
Researchers from Mass General Brigham, led by Ali Azarbarzin, examined data from two large, well-established sleep research cohorts: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Sleep Heart Health Study (SHHS). Both track respiratory events during sleep using multiple simultaneous measurements, which let the team compare how different scoring methods performed across racial groups.
A Measurement Gap, Not a Disease Gap
Sleep apnea severity is conventionally scored by counting breathing pauses that coincide with a drop in blood oxygen saturation of at least 4%, as detected by pulse oximetry. That oxygen-desaturation threshold is the backbone of the apnea-hypopnea index used to decide who gets diagnosed, who gets referred for treatment, and who qualifies for a CPAP machine.
The researchers instead cross-checked desaturation-based scoring against airflow signals, which directly detect when breathing is disrupted regardless of what happens to blood oxygen afterward. The gap was substantial: among respiratory events that airflow monitoring confirmed were occurring, pulse-oximetry-based scoring identified 21% fewer of them in Black participants than in white participants in the MESA cohort, and 20% fewer in the SHHS cohort. The underlying breathing disruptions were there — the oxygen-based method was simply less likely to register them.
Why It Matters Beyond the Number
The consequences of that measurement gap aren't just academic. The researchers also calculated a heart-rate-based severity measure that doesn't depend on oxygen saturation at all, and found that this alternative metric was associated with cardiovascular events and death among Black participants in both cohorts — a signal that oxygen-based scoring alone may be missing clinically important risk.
Because diagnosis, referral to treatment, and insurance coverage for devices like CPAP all hinge on where a patient's apnea-hypopnea index falls relative to standard thresholds, a scoring method that consistently undercounts events in one group of patients could mean real cases of moderate or severe sleep apnea go untreated, not because the disease is milder, but because the tool measuring it responded differently.
Azarbarzin was careful to frame the finding as a measurement problem rather than a call for race-adjusted diagnostic criteria: "We are not suggesting different diagnostic thresholds based on race; rather, we think the underlying measurements need to be accurate and reliable across all patients." The physiological reasons pulse oximetry might behave differently across patients aren't fully settled, though prior research has pointed to factors affecting how light-based oxygen sensors interact with skin and tissue, and individual differences in arousal and chemoreflex responses to breathing disruptions.
Building on Earlier Warning Signs
This isn't the first time pulse oximetry's reliability has been questioned in Black patients. A 2023 American Thoracic Society conference report using MESA data had already found that desaturation sensitivity was lower in Black patients compared with white patients after statistical adjustment, even though overall apnea-hypopnea index values were similar between the two groups. The new study extends that earlier signal across two separate national cohorts and directly ties the measurement discrepancy to a cardiovascular outcome, strengthening the case that this is a reproducible pattern rather than a one-cohort anomaly.
What This Means for Patients
Patients shouldn't assume their home sleep test or in-lab study is unreliable, but the findings are a reminder that a "normal" or "mild" severity score from a pulse-oximetry-based test doesn't rule out clinically significant sleep apnea, particularly for Black patients who have symptoms — loud snoring, witnessed pauses in breathing, severe daytime fatigue, or treatment-resistant high blood pressure — that seem out of proportion to their reported score. Patients in that situation should ask their sleep physician whether additional airflow or heart-rate-based data from their study can be reviewed, rather than relying on the oxygen-desaturation index alone. For clinicians and sleep labs, the study adds to a growing case for incorporating multiple physiological signals, not just blood oxygen, into how apnea severity is scored, so that treatment decisions reflect the actual burden of disrupted breathing rather than an artifact of how one sensor responds.